Comparison between C.Mahendra Exports IPO and Claris Lifesciences IPO.
C.Mahendra Exports IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Claris Lifesciences IPO is a Mainboard Bookbuilding proposed to list at BSE.
The total issue size of C.Mahendra Exports IPO is up to ₹165.00 Cr whereas the issue size of the Claris Lifesciences IPO is up to ₹300.00 Cr. The final issue price of C.Mahendra Exports IPO is ₹110.00 per share and of Claris Lifesciences IPO is ₹228.00 per share.
| C.Mahendra Exports IPO | Claris Lifesciences IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹95.00 per share | ₹228.00 per share |
| Issue Price (Upper) | ₹110.00 per share | ₹235.00 per share |
| Issue Price (Final) | ₹110.00 per share | ₹228.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 60 shares | 22 shares |
| Fresh Issue Size | 1,50,00,000 shares | 1,26,32,477 shares |
| Fresh Issue Size (Amount) | up to ₹165.00 Cr | up to ₹300.00 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 1,50,00,000 shares | 1,26,32,477 shares |
| Issue Size Total (Amount) | up to ₹165.00 Cr | up to ₹300.00 Cr |
C.Mahendra Exports IPO opens on Dec 31, 2010, while Claris Lifesciences IPO opens on Nov 24, 2010. The closing date of C.Mahendra Exports IPO and Claris Lifesciences IPO is Jan 06, 2011, and Dec 02, 2010, respectively.
| C.Mahendra Exports IPO | Claris Lifesciences IPO | |
|---|---|---|
| Anchor Bid Date | Nov 23, 2010 | |
| Issue Open | Dec 31, 2010 | Nov 24, 2010 |
| Issue Close | Jan 06, 2011 | Dec 02, 2010 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Jan 20, 2011 | Dec 20, 2010 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
C.Mahendra Exports IPO P/E ratio is , as compared to Claris Lifesciences IPO P/E ratio of .
| C.Mahendra Exports IPO | Claris Lifesciences IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 100 | 86.03 | ||||
| Promoter Shareholding (Post-Issue) | 0.75 | 0.69 | ||||
| P/E Ratio | ||||||
| Market Cap | ₹660.00 Cr. | ₹1455.05 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW | 1.54 | 24.15 |
In the C.Mahendra Exports IPO Retail Individual Investors (RII) are offered 52,50,000 shares while in Claris Lifesciences IPO retail investors are offered 52,50,000 shares. Qualified Institutional Buyers (QIB) are offered 75,00,000 shares in C.Mahendra Exports IPO and 57,36,484 shares in Claris Lifesciences IPO.
| C.Mahendra Exports IPO | Claris Lifesciences IPO | |
|---|---|---|
| Anchor Investor Reservation | 18,43,003 shares | |
| Market Maker Reservation | ||
| QIB | 75,00,000 shares | 57,36,484 shares |
| NII | 22,50,000 shares | 12,63,247 shares |
| RII | 52,50,000 shares | 37,89,743 shares |
| Employee | ||
| Others | ||
| Total | 1,50,00,000 shares | 1,26,32,477 shares |
C.Mahendra Exports IPO subscribed 2.78x in total, whereas Claris Lifesciences IPO subscribed 1.05x.
| C.Mahendra Exports IPO | Claris Lifesciences IPO | |
|---|---|---|
| QIB (times) | 1.02x | 1.04x |
| NII (times) | 3.92x | 1.72x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 4.82x | 1.35x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 2.78x | 1.05x |
